Other reported NRF2 agonists with potential AD-modifying effects include flavonoids (eriodictyol), polyphenols (tannic acid), terpenoids (ginkgolide B), and lignans (forsythiaside A) (324–327) (Figure 7). This evidence concerns the gene NFE2L2 and Alzheimer disease.